Veterinary Medicine Information website

Ovipast Plus suspension for injection for sheep

Authorised
  • Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
  • Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
  • Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
  • Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
  • Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
  • Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
  • Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
  • Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
  • Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated

Product identification

Medicine name:
Ovipast Plus suspension for injection for sheep
Active substance:
  • Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
  • Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
  • Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
  • Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
  • Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
  • Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
  • Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
  • Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
  • Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
Target species:
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
    500000000.00
    cells
    /
    1.00
    millilitre(s)
  • Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
    500000000.00
    cells
    /
    1.00
    millilitre(s)
  • Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
    500000000.00
    cells
    /
    1.00
    millilitre(s)
  • Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
    500000000.00
    cells
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
    500000000.00
    cells
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
    500000000.00
    cells
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
    500000000.00
    cells
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
    500000000.00
    cells
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
    500000000.00
    cells
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB02
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:
  • box containing 1 vial of 500 ml
  • box containing 1 vial of 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
  • MSD Animal Health UK Limited
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 62891/05/25-01-2008/K-0140301
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0326/001
Concerned member states:
  • Greece
  • Ireland
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 24/07/2025
Download

Summary of Product Characteristics

English (PDF)
Published on: 22/10/2025
Download
Greek (PDF)
Published on: 2/10/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 2/10/2025